| Volume group | Dobutamine group |
---|---|---|
Intraoperatively | Â | Â |
   Operation time (min) | 315 ± 109 | 331 ± 132 |
   Total volume (l/hour) | 1.31 ± 0.54 (0.97/1.21/1.54) | 1.35 ± 0.43 (1.05/1.29/1.65) |
   Red blood cells (ml) | 609 ± 244 (480/600/600) | 713 ± 458 (500/600/650) |
   Number of transfused patients (%) | 11 (44%) | 12 (48%) |
   Dobutamine doses (μg/kg/minute) | 3.5 ± 0.7 | 5.5 ± 1.8 |
   Dobutamine (number of patients) | 2 (8%) | 25 (100%)* |
   Initial serum lactate (mEq/l) | 1.3 ± 0.6 | 1.3 ± 0.5 |
   Final serum lactate (mEq/l) | 1.7 ± 0.7 | 1.9 ± 0.9 |
   Initial mixed venous oxygen saturation | 83 ± 4 | 81 ± 6 |
   Final mixed venous oxygen saturation | 86 ± 4 | 86 ± 7 |
   Number of goal-achievers | 7 (28%) | 21 (84%)* |
Intensive care unit | Â | Â |
   Total volume (l/hours) | 0.29 ± 0.12 | 0.28 ± 0.18 |
   Red blood cells (ml) | 1064 ± 684 (450/600/900) | 650 ± 226* (600/600/600) |
   Number of transfused patients (%) | 7 (28%) | 6 (24%) |
   Dobutamine doses (μg/kg/minute) | 5.7 ± 2.3 | 6.1 ± 3.4 |
   Dobutamine (number of patients) | 6 (24%) | 20 (80%)* |
   Sodium nitroprusside | 6 (24%) | 2 (8%) |
   Initial serum lactate (mEq/l) | 2.5 ± 1.6 | 2.2 ± 0.8 |
   Final serum lactate (mEq/l) | 1.9 ± 2.0 | 1.3 ± 0.4 |
   Initial mixed venous oxygen saturation | 76 ± 13 | 78 ± 9 |
   Final mixed venous oxygen saturation | 78 ± 9 | 77 ± 8 |
   Number of goal-achievers | 16 (64%) | 22 (88%)* |